Lataa...

A dose escalation trial for the combination of erlotinib and sirolimus for recurrent malignant gliomas

In order to achieve higher dosages than previously used in clinical trials, we conducted a phase I trial to determine the maximum tolerated dose (MTD) for the combination of erlotinib and sirolimus for the treatments of recurrent malignant gliomas. Patients with pathologically proven World Health Or...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Nghiemphu, Phioanh Leia, Lai, Albert, Green, Richard M., Reardon, David A., Cloughesy, Timothy
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer US 2012
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3472078/
https://ncbi.nlm.nih.gov/pubmed/22918789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-012-0960-y
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!